Advertisement
U.S. markets closed

SinoMab BioScience Limited (3681.HK)

HKSE - HKSE Delayed Price. Currency in HKD
1.560+0.040 (+2.63%)
At close: 03:12PM HKT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
Market Cap (intraday)
1.70B
Enterprise Value
1.79B
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
1.06k
Price/Book (mrq)
3.87
Enterprise Value/Revenue
1.31k
Enterprise Value/EBITDA
-6.68

Trading Information

Stock Price History

Beta (5Y Monthly) 0.76
52-Week Change 3-13.81%
S&P500 52-Week Change 327.86%
52 Week High 32.070
52 Week Low 31.030
50-Day Moving Average 31.441
200-Day Moving Average 31.415

Share Statistics

Avg Vol (3 month) 3133.81k
Avg Vol (10 day) 3208.25k
Shares Outstanding 51.09B
Implied Shares Outstanding 61.09B
Float 8298.81M
% Held by Insiders 142.74%
% Held by Institutions 119.50%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)2,947.04%

Management Effectiveness

Return on Assets (ttm)-15.46%
Return on Equity (ttm)-60.39%

Income Statement

Revenue (ttm)4.39M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -214.94M
Net Income Avi to Common (ttm)-243.11M
Diluted EPS (ttm)-0.300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)234.66M
Total Cash Per Share (mrq)0.23
Total Debt (mrq)450.81M
Total Debt/Equity (mrq)152.51%
Current Ratio (mrq)1.57
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-133.85M
Levered Free Cash Flow (ttm)-198.61M